HIV with Hep C Risk Factors | Medical Algorithm

Evaluation

Are you evaluating a patient coinfected with HCV and HIV?

Yes

Do you have to treat the HIV with antiretroviral therapy now?

Yes

Has the patient shown a sustained HCV response to ribavirin and interferon alpha?

Yes

Is the patient receiving didanosine now?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for progression in hepatic fibrosis

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Criteria of Schoeniger-Hekele and Mueller for Using CA19-9 and CA125 to Diagnose Severe Liver Fibrosis in a Pateint with Noncholestatic Liver Disease

Therapy

Selection

Monitoring

Disease Progression

Specialty

Gastroenterology
Infectious Diseases

Objective

risk factors
disease progression

ICD-10

K74.0 - Hepatic fibrosis
B23.0 - Acute HIV infection syndrome
B18.2 - Chronic viral hepatitis C
K71.9 - Toxic liver disease, unspecified

Risk Factors for Progression of Hepatic Fibrosis in Patient Coinfected with HIV & Hepatitis C

Purpose: To evaluate a patient coinfected with HIV and HCV for risk factors associated with progression of hepatitic fibrosis.